+Compare
GSK
Stock ticker:
NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
70.99B

GSK Price Prediction, GSK plc AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
GSK Trading results, last 6 months
AI Robots NameP/L
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EST Feb 06, 2023

GSK in upward trend: price may jump up because it broke its lower Bollinger Band on January 05, 2023

GSK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 23 of 46 cases where GSK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 50%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

GSK moved above its 50-day moving average on February 06, 2023 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GSK advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 243 cases where GSK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where GSK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on February 02, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on GSK as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GSK turned negative on January 24, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for GSK crossed bearishly below the 50-day moving average on February 03, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GSK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.669) is normal, around the industry mean (4.902). P/E Ratio (13.441) is within average values for comparable stocks, (35.474). Projected Growth (PEG Ratio) (1.117) is also within normal values, averaging (3.890). GSK's Dividend Yield (0.054) is considerably higher than the industry average of (0.027). P/S Ratio (2.043) is also within normal values, averaging (4.364).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GSK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GSK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

AI
A.I. Advisor
published Earnings

GSK is expected to report earnings to fall 26.17% to 66 cents per share on July 27

GSK plc GSK Stock Earnings Reports
Q2'22
Est.
$0.67
Q4'22
Beat
by $0.36
Q3'22
Missed
by $0.49
Q1'22
Beat
by $0.04
Q4'21
Beat
by $0.04
The last earnings report on February 01 showed earnings per share of 90 cents, beating the estimate of 54 cents. With 4.93M shares outstanding, the current market capitalization sits at 70.99B.
AI
A.I.Advisor
published Dividends

GSK paid dividends on January 12, 2023

GSK plc GSK Stock Dividends
А dividend of $0.32 per share was paid with a record date of January 12, 2023, and an ex-dividend date of November 17, 2022. Read more...
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), Eli Lilly & Co (NYSE:LLY), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Pfizer (NYSE:PFE), AstraZeneca PLC (NASDAQ:AZN), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 76.41B. The market cap for tickers in the group ranges from 57.22K to 427.1B. JNJ holds the highest valuation in this group at 427.1B. The lowest valued company is CRXTQ at 57.22K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -1%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 3%. DCHPF experienced the highest price growth at 15%, while JCRRF experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -17%. For the same stocks of the Industry, the average monthly volume growth was -14% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 25
P/E Growth Rating: 50
Price Growth Rating: 50
SMR Rating: 55
Profit Risk Rating: 63
Seasonality Score: -27 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published General Information

General Information

a manufacturer of vaccines and other pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
980 Great West Road
Phone
+44 2080475000
Employees
90096
Web
https://www.gsk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTCM3.80-0.01
-0.26%
BIT Mining Limited
VIR29.80-0.34
-1.13%
Vir Biotechnology
DVN60.14-0.71
-1.17%
Devon Energy Corp
DNN1.32-0.05
-3.65%
Denison Mines Corp
CRGE1.44-0.14
-8.86%
Charge Enterprises

GSK and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSK has been loosely correlated with SNY. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then SNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
+1.46%
SNY - GSK
40%
Loosely correlated
-0.35%
NVS - GSK
25%
Poorly correlated
-0.44%
GILD - GSK
22%
Poorly correlated
+2.20%
AZN - GSK
22%
Poorly correlated
+0.13%
PFE - GSK
20%
Poorly correlated
-0.68%
More